The Education Core will continue to be a shared resource for interdisciplinary research in Alzheimer's disease and related disorders (AD). Working in close collaboration with the Clinical Core, the Ed Core seeks to advance the goals ofthe ADRC through recruitment of participants, especially of under-represented groups, into AD research;through education of the public and health care providers about AD diagnosis, treatment, and research;and through establishment of programs and partnerships that aid in developing AD research and clinical skills across many disciplines. In collaboration with the Alzheimer's Association Georgia Chapter (AAGC) and with new partnerships to be developed in the proposed project, the Ed Core will continue to provide current and comprehensive information about AD research and treatment to a variety of target audiences including patients, caregivers, healthcare personnel, and the public. Special emphasis in our educational efforts will be placed on issues related to Mild Cognitive Impairment and early diagnosis and to reaching out and improving care provided to minority and underrepresented populations. The Core will pursue three aims: 1) strengthen structure and structural linkages to leverage resources to provide education and information and to foster recruitment;2) provide education and information to patients and families, health care providers, and researchers;3) strengthen and expand interdisciplinary linkages to develop innovative strategies for education and recruitment. Successful strategies from the current project will be continued (collaboration with other ADRC cores;partnering with community organizations for educational planning and programming;extensive education to health care professionals;innovative strategies for reaching the African American community for education and recruitment). Several innovations will be introduced, including the addition of at least two community partnerships comparable to that currently in place with the Alzheimer's Association;use of social networking strategies to extend dissemination reach;and development of collaborative relationships with academic units not typically involved in AD research (e.g., sociology, theology) to develop innovative education programs.
The Education Transfer Core works with other ADRC cores and key community partner organizations to provide to patients, families, health care providers and students, and researchers and their students education and information about Alzheimer's disease and Alzheimer's research. This transfer function is meant to raise awareness of Alzheimer's and Alzheimer's research and to recruit people into Alzheimer's research. Special emphasis is placed on recruitment of African Americans and other minorities.
|Rangaraju, Srikant; Raza, Syed Ali; Li, Noel Xiang'An et al. (2018) Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes-Activation and Age-Related Effects. Front Immunol 9:405|
|Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25|
|Chalermpalanupap, Termpanit; Schroeder, Jason P; Rorabaugh, Jacki M et al. (2018) Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. J Neurosci 38:74-92|
|Maezawa, Izumi; Nguyen, Hai M; Di Lucente, Jacopo et al. (2018) Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept. Brain 141:596-612|
|Bishof, Isaac; Dammer, Eric B; Duong, Duc M et al. (2018) RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease. J Biol Chem 293:11047-11066|
|Peng, Katherine Y; Pérez-González, Rocío; Alldred, Melissa J et al. (2018) Apolipoprotein E4 genotype compromises brain exosome production. Brain :|
|Zhang, Qi; Ma, Cheng; Gearing, Marla et al. (2018) Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease. Acta Neuropathol Commun 6:19|
|Gangishetti, Umesh; Christina Howell, J; Perrin, Richard J et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimers Res Ther 10:98|
|Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169|
|Umoh, Mfon E; Dammer, Eric B; Dai, Jingting et al. (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48-62|
Showing the most recent 10 out of 444 publications